Mckesson Corp: (NYSE: MCK)

$113.93

-0.69 (-0.60%)

Volume 1,158,770

Jun 19 04:03 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		113.92 - 115.95
	
		52wk Low - High
		84.65 - 119.32
	
		Previous Close
		114.62
	
		Avg. Volume
		1,062,569
	
		Industry
		RETAIL-DRUG STR
	
		Market Cap
		26.19 B
	
		Div - Yield
		0.80 - 0.70
	
		Beta
		0.78
	
		P/E (F1)
		14.24
	
		Current Year Est.
		8.05
	
		Quarterly Earnings ESP 
		NA
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		80 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/9/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            14.24
                        
                            PEG Ratio
                            1.10
                        
                            Current Year Est.
                            8.05
                        
                            Current Quarter Estimate
                            1.66
                        
                            Most Accurate Estimate
                            NA
                        
                            Earnings ESP 
                            NA
                        
                            Next Earnings Report Date
                            07-25-2013
                        
                            EPS Last Year
                            7.18
                        
                            Expected Earnings Growth
                            13.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
McKesson Corporation, the world's largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. The Company is organized under two operating segments: Health Care Supply Management and Health Care Information Technology.   
Full MCK Company Report

 Analyst Report on MCK

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
MCK Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (03/2014)	Next Year (03/2015)
Average Estimate	1.66	2.07	8.05	9.14
Number of Estimates	7	7	9	8
Low Estimate	1.63	2.00	8.00	8.80
High Estimate	1.79	2.16	8.09	NA
Year Ago EPS	1.55	1.92	7.20	8.05
EPS Growth	7.37%	8.04%	11.76%	13.59%

More MCK Estimates

Average Earnings Estimates for MCK

EPS Growth for MCK

Industry Analysis

Name	Symbol	Previous Close
MCKESSON CORP	MCK	114.62
GNC HOLDINGS	GNC	47.93
HERBALIFE LTD	HLF	49.55
RITE AID CORP	RAD	3.13
AMERISOURCEBRGN	ABC	55.86
BIOSCRIP INC	BIOS	15.98
CARDINAL HEALTH	CAH	48.76
CVS CAREMARK CP	CVS	59.91
PHARMERICA CORP	PMC	16.20
WALGREEN CO	WAG	50.90

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

COMPARE TICKER vs. Its Peers

Zacks Commentary

Will Rite Aid Beat Earnings Est. Again?

Jun 17, 2013

McKesson Earnings Down in 4Q

May 08, 2013

The Zacks Analyst Blog Highlights: AmerisourceBergen, Walgreen, Cardinal Health, McKesson and St. Jude Medical

Mar 21, 2013

AmerisourceBergen Inks Deal

Mar 20, 2013

HSIC Discusses 2013 Biz Environment

Mar 13, 2013

McKesson Acquires PSS World Medical

Feb 26, 2013

McKesson Misses in 3Q

Feb 01, 2013

Omnicell in Arab Health Conference

Jan 28, 2013

More MCK Zacks Commentary

Financials

EPS TTM	7.18
Sales	122,455
Net Income	1,338
Price/Earnings	15.96
Price/Book	3.78
Price/Cash Flow	11.55
Price/Sales	0.21

More MCK Financials

News

Despite a Big Contract Loss, This Healthcare Service Company is a Buy - TheMotleyFool

Jun 19, 2013

McKesson Corporation to Webcast Investor Day - Businesswire

Jun 19, 2013

Watch for Shares of McKesson (MCK) to Approach Resistance at $115.90 - Financial News Network Online - Pivot Alerts

Jun 18, 2013

Finding Strength in Healthcare Supplies - TheMotleyFool

Jun 17, 2013

McKesson (MCK) Showing Bullish Technicals But Could Fall Through $112.58 Support - Freshbrewedmedia

Jun 17, 2013

Top 3 Companies in the Health Care Distributors Industry With the Lowest P/E Ratio (PMC, CAH, MCK) - Financial News Network Online - News Corner

Jun 17, 2013

McKesson has the Highest EBITDA Growth in the Health Care Distributors Industry (MCK, MWIV, OMI) - Financial News Network Online - News Corner

Jun 14, 2013

Global Pharmacy Automation Market Report 2013-2016: McKesson Corp, ScriptPro, Parata Systems and Swisslog Holdings Dominate - M2

Jun 13, 2013

See All News Stories on MCK

Broker Recommendations

Current ABR	1.77
ABR (Last Week)	1.77
# of recs in ABR	13
Average Target Price	115.44
Industry Rank by ABR	80 out of 265
Rank in Industry	4 out of 11

More MCK Broker Recommendations

Day Low - High	113.92 - 115.95
52wk Low - High	84.65 - 119.32
Previous Close	114.62
Avg. Volume	1,062,569
Industry	RETAIL-DRUG STR
Market Cap	26.19 B
Div - Yield	0.80 - 0.70
Beta	0.78
P/E (F1)	14.24
Current Year Est.	8.05
Quarterly Earnings ESP	NA

P/E (F1)	14.24
PEG Ratio	1.10
Current Year Est.	8.05
Current Quarter Estimate	1.66
Most Accurate Estimate	NA
Earnings ESP	NA
Next Earnings Report Date	07-25-2013
EPS Last Year	7.18
Expected Earnings Growth	13.00%

Username: Password:

Remember me [?]

Mckesson Corp: (NYSE: MCK)

$113.93

-0.69 (-0.60%)

Volume 1,158,770

Jun 19 04:03 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

Zacks Commentary

Financials

News

Broker Recommendations